Login

Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

June 18, 2021
BioUtah News Utah's Life Sciences Companies
Blackrock Neurotech Closes $10M Financing Round To Advance Development Of Its World-Leading Brain-Computer Interface (BCI) Technology

Blackrock Neurotech, the world’s leading platform for brain-computer interface (BCI) technology and manufacturing, has closed a $10 million financing round, led by Christian Angermayer’s re.Mind Capital with participation from Peter Thiel, German entrepreneur Tim Sievers, and Sorenson Impact’s University Venture Fund II. The funding will further expand programs on the Blackrock platform, including clinical studies […]

June 18, 2021
Policy News
Biden Administration Recommends Policy Changes to Secure U.S. Pharmaceutical Supply Chain

In last week’s BioUtah News and Events, we highlighted the Biden Administration’s formation of a task force to address a range of supply chain issues. This week, we share the findings of the administration’s 100-day assessment of critical supply chains, undertaken pursuant to President Biden’s February 2021 “America’s Supply Chains” executive order addressing supply chain […]

June 18, 2021
BioUtah News State News Utah's Life Sciences Companies
ARUP Celebrates Opening of a New State-of-the-Art Laboratory Facility in Salt Lake City

Founded in 1984, ARUP Laboratories, one of the nation’s largest reference laboratories, on Tuesday held a ribbon cutting ceremony to officially open its new four-story, 220,000-square-foot laboratory facility located in University of Utah Research Park. The newly constructed facility is the crown jewel of eight properties ARUP now owns and operates as Research Park’s largest […]

June 11, 2021
Policy News
Elute Receives FDA Authorization For Its First Clinical Trial Using Antibiotic Eluting Bone Void Filler

Elute has received an Investigational Device Exemption (IDE) authorization from the FDA to use its EP Granules with TobramycinTM in a pivotal clinical trial. This IDE investigates the use of a resorbable bone void filler that delivers a broad-spectrum antibiotic in the surgical treatment of bone infections following hip or knee replacements. This is the […]

June 11, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Renalytix Announces Leadership Additions for Expanding KidneyIntelX Deployment

RenalytixAI has announced a series of key hires to drive its commercialization strategy in the U.S. market in light of the recently announced Federal Government General Service Administration payment contract and additional large healthcare system partnerships. The combined background and experience of the new leadership team is expected to drive adoption of the KidneyIntelX testing […]

June 11, 2021
BioUtah News Utah's Life Sciences Companies
How St. George Became the Epicenter for a Major Global Genetics Study

The St. George Chamber of Commerce recently held a special luncheon with a presentation by Travis Sheffield, operations director for Intermountain Precision Genomics on “How St. George Became the Epicenter for a Major Global Genetics Study”. Sheffield, who is leading the HerediGene Population Study throughout Utah, Idaho, and soon in Nevada, presented the ins and […]

June 11, 2021
BioUtah News Industry News Life Sciences Industry News Utah's Life Sciences Companies
Altitude Lab Launches Investor Coalition to Fund and Mentor Healthcare Startups in Utah

On June 8, Altitude Lab has announced the launch of its Investor Coalition, a partnered network of leading healthcare venture capitalists to fund, mentor, and provide resources for Altitude-incubated startups. Together, the investor coalition aims to collectively invest $50 million in Altitude’s startups over the next three years, specifically supporting diverse and underrepresented founders. In […]

June 11, 2021
Policy News
Senate Passes Endless Frontiers Act to Boost U.S. Innovation

On Tuesday, the U.S. Senate passed the Endless Frontier Act to boost U.S. innovation and out-compete China. The bill passed the Senate by a vote of 68-32. The bill would provide $120 billion to the NSF, DOE and NASA to support research and develoopment in key technology areas critical to our national security, including biotechnology […]

June 9, 2021
Press Releases
BioUtah Statement on Launch of Altitude Lab’s Investor Coalition to Fund and Mentor Utah’s Life Sciences Startups

Salt Lake City – BioUtah President and CEO, Kelvyn Cullimore, issued the following statement upon the launch of Altitude Lab’s Investor Coalition to fund and mentor life sciences startups in Utah. BioUtah President and CEO, Kelvyn Cullimore, issued the following statement upon the launch of Altitude Lab’s Investor Coalition to fund and mentor life sciences […]

June 4, 2021
BioUtah News Industry News Utah's Life Sciences Companies
Scientia Raises $50M to Develop Devices for Stroke, Cancer Treatment

Scientia announced it has raised $50M in growth equity financing from Vivo Capital, a Palo Alto, CA-headquartered global healthcare investment firm. The financing will be used to accelerate sales, marketing, and new product development in both its core neurovascular stroke market as well as adjacent markets in peripheral vascular and interventional oncology. “We are excited […]

June 4, 2021
BioUtah News Economic Developments State News
Utah #1 For Best State Economic Outlook…Again

Utah has done it again! The 2021 “Rich States, Poor States” report recently released by the American Legislative Exchange Council (ALEC) ranks Utah as the state with the strongest economic outlook in the nation. Utah has held this first place designation for the past 14 years. View state-by-state data HERE. To determine its rankings, the […]

June 4, 2021
BioUtah News Industry News Utah's Life Sciences Companies
Utility Study Indicates KidneyIntelX Risk Assessment can Address Treatment Ambiguity in Primary Care

RenalytixA has announced results from a new utility study. The study confirms the importance of risk assessment testing in addressing treatment ambiguity in the early stages of diabetic kidney disease (DKD) and improving patient engagement and adherence – two major barriers to slowing or preventing DKD progression and preserving kidney health. In clinical studies, KidneyIntelX […]